News
HAE
78.40
+1.27%
0.99
ZBH Stock to Benefit From Global Expansion Despite Macro Issues
NASDAQ · 1h ago
Labcorp's New Alliance With Graves Gilbert Clinic Set to Boost Stock
NASDAQ · 2h ago
Lucid Inks New Partnership With VITALExam: Stock to Gain?
NASDAQ · 4h ago
Should Prestige Consumer Stock Stay in Your Portfolio Right Now?
NASDAQ · 5h ago
Here's Why You Should Add HAE Stock to Your Portfolio Now
NASDAQ · 2d ago
Reasons to Add GMED Stock to Your Portfolio Right Now
NASDAQ · 2d ago
Hologic Teams Up With the CDC to Combat H5N1 Bird Flu: Stock to Gain?
NASDAQ · 2d ago
Align Shares Down on Macroeconomic Issues, ASP Challenges
NASDAQ · 3d ago
Should You Retain Teleflex Stock in Your Portfolio Right Now?
NASDAQ · 3d ago
Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain?
NASDAQ · 3d ago
Weekly Report: what happened at HAE last week (1216-1220)?
Weekly Report · 3d ago
Bruker Adds Another 1.2 GHz NMR System in Switzerland, Stock Climbs
Barchart · 3d ago
Haemonetics: Strong Market Position and Attractive Investment Opportunity Amid Growth in Plasma and Hospital Segments
TipRanks · 5d ago
MYGN Stock Might Gain From the New Recognition of RiskScore Study
NASDAQ · 6d ago
Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain?
NASDAQ · 12/19 12:27
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
NASDAQ · 12/19 12:24
Look Under The Hood: IYY Has 13% Upside
NASDAQ · 12/19 11:52
ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker
NASDAQ · 12/18 12:48
NEOG Stock Gains From New Addition to the Petrifilm Product Line
NASDAQ · 12/18 12:38
Reasons to Retain STE Stock in Your Portfolio Now
NASDAQ · 12/17 16:48
More
Webull provides a variety of real-time HAE stock news. You can receive the latest news about Haemonetics Corp Mass through multiple platforms. This information may help you make smarter investment decisions.
About HAE
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment includes blood collection and processing devices and disposables for red cells, platelets and whole blood. The Company’s Hospital segment consists of Interventional Technologies, which includes vascular closure devices and sensor-guided technologies, and Blood Management Technologies, which includes devices and methodologies for measuring coagulation characteristics of blood, and blood transfusion management software, among others.